“dana-farber-cancer-institute” Archives

in
Entry Author Date Location
Sanford-Burnham Strikes Deal With J&J, Second Big Pharma Alliance in a Month 01/17/11 San Diego
Bayer Nuzzles Up Even Closer to UCSF, Strikes 10-Year Master R&D Agreement 01/10/11 San Francisco
Top Five Biotech Surprises & Innovations of 2010, and Five Trends to Watch for in 2011 12/30/10 San Francisco
Pearl Therapeutics Beats $3B Lung Drug, Anacor’s Flat IPO, Medtronic Buys Ardian for $800M, & More Bay Area Life Sciences News 12/03/10 San Francisco
Accelerator’s East Coast Foray, Gates Foundation Bets on RSV Vaccine, UW Sues GE, & More Seattle-Area Life Sciences News 12/02/10 Seattle
Novartis Takes Aim at Bay-Area Biotech with Dana-Farber Roots in Legal Battle Over Potential Lung Cancer Drugs 12/02/10 Boston
How To Keep Academic/Big Pharma Alliances from Going off the Rails 11/30/10 San Diego
Lilly Funds Cerulean, Genzyme Sells Diagnostics Unit, Roche Ends RNAi Program, & More Boston-Area Life Sciences News 11/19/10 Boston
Report: UCSF Strikes $85M Deal With Pfizer to Develop Biotech Drugs 11/15/10 San Francisco
Avila Therapeutics Pursuing Rival to Lung Cancer Drug in Dana-Farber Lawsuit 11/12/10 Boston
Complete Genomics Goes Public, 23andMe Raises $22M, Genomic Health’s Dx Vision, & More Bay Area Life Sciences News 11/12/10 San Francisco
Bay Area Biotech Startup at Odds with Dana-Farber and Novartis Over Cancer Drug Rights 10/28/10 Boston
Dana Farber Gets $33M from Sanofi, Astellas Backs DecImmune, Ironwood Sells Microbia, & More Boston-Area Deals News 09/29/10 Boston
Dana Farber Gets $33M in Sanofi Deal 09/23/10 Boston
Aileron Inks Deal with Roche, Worth Up to $1.1B, to Develop Stapled Peptide Drugs 08/24/10 Boston
On-Q-ity, Led by Former Genzyme Exec, Takes on “Diagnostic Black Hole” in Cancer 07/07/10 Boston
Genentech’s Souped-Up Herceptin: The Odyssey Toward a More Powerful Breast Cancer Drug 06/14/10 San Francisco
Sage Bionetworks Snaps Up $6.7M Grant to Train Young Network Biologists 02/23/10 Seattle
Biogen Drops Facet Bid, Aveo Reveals IPO Ambitions, Pfizer Partners with Adimab, & More Boston-Area Life Sciences News 12/23/09 Boston
Breast Cancer “Smart Bomb” Drug From Roche, ImmunoGen Passes Important Trial 12/12/09 Boston
Supercharged Herceptin Nears Pivot Point, as ImmunoGen, Roche Await Data on Breast Cancer “Smart Bomb” 12/07/09 Boston
Aileron’s New Class of Drugs Shown to Get Inside Cells to Block Prime Cancer Target 11/11/09 Boston
Tokai Pushes Edge With Three-Pronged Attack on Prostate Cancer 11/10/09 Boston
HubSpot Spots $16M, Synageva BioPharma Secures $12M, Currensee Sews Up $6M, & More Boston-Area Deals News 10/23/09 Boston
Nuclea Nabs $3.4M Deal 10/22/09 Boston
Fate Therapeutics Growing Fast on “Industrialized” Stem Cell Technology 09/30/09 National
Helicos Biosciences, Running Low on Cash, Snaps Up $10M Lifeline 09/16/09 Boston
Biogen Idec Faces Suit From Partner Elan, Genzyme Wins European Approval for Stem-Cell Boosting Drug, Alnylam Teams with Tekmira, & More Boston-Area Life Sciences News 08/12/09 Boston
Genzyme Faces Lawsuit and Competition, Vertex Gathers More Cash for Telprevir, Cardiorobotics Corrals $11.6M, & More Boston-Area Life Sciences News 08/05/09 Boston
Vertex Scores $105M For Asian Telaprevir Rights, Avila Avails Itself of $30M, IBM Picks Up Ounce Labs, & More Boston-Area Deals News 07/31/09 Boston
Page 2 of 3 « previous page · next page »